To address this issue, we have engineered a multi-epitope antigen using synthetic biology tools and developed a serological test that detects the presence of dengue specific IgM and IgG without cross-reaction to Zika-infected sera and that can be readily re-tailored to new emerging DENV. This evidence concerns the gene CD40LG and dengue disease.